Soluble Ferric Pyrophosphate (SFP)

DRUG3 trials

Sponsors

Charles Drew University of Medicine and Science, Rockwell Medical Technologies, Inc.

Conditions

End Stage Renal Disease (ESRD)Renal Failure Chronic Requiring Hemodialysis

Phase 3

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients

CompletedNCT01320202

Rockwell Medical Technologies, Inc.Renal Failure Chronic Requiring Hemodialysis

Start: 2011-03-31End: 2013-11-30Updated: 2017-04-26

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)

CompletedNCT01322347

Rockwell Medical Technologies, Inc.Renal Failure Chronic Requiring Hemodialysis

Start: 2011-04-30End: 2014-02-28Updated: 2017-04-26

Unknown Phase

Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients

TerminatedNCT00604565

Charles Drew University of Medicine and ScienceEnd Stage Renal Disease (ESRD)

Start: 2008-01-31End: 2010-12-31Updated: 2015-08-31